UNIVERSITY OF WASHINGTON
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Marketing Workplace Chronic Disease Prevention
Not Applicable
Completed
- Conditions
- Health BehaviorChronic Disease
- Interventions
- Behavioral: Workplace Solutions Consulting approachBehavioral: Delayed intervention
- First Posted Date
- 2007-03-28
- Last Posted Date
- 2009-11-20
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 48
- Registration Number
- NCT00452816
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)
Not Applicable
Completed
- Conditions
- Mild Cognitive ImpairmentDementia
- Interventions
- Behavioral: Resources and Activities for Life Long Independence (RALLI)Behavioral: Social Walking program (SW)
- First Posted Date
- 2007-03-12
- Last Posted Date
- 2012-10-19
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 181
- Registration Number
- NCT00446394
- Locations
- 🇺🇸
Northwest Research Group on Aging, Department of Psychosocial and Community Health, University of Washington School of Nursing, Seattle, Washington, United States
Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
Phase 2
Completed
- Conditions
- Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGAHypertension, Renal
- First Posted Date
- 2007-03-12
- Last Posted Date
- 2010-04-15
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 45
- Registration Number
- NCT00446459
- Locations
- 🇺🇸
Universtiy of Washington Medical Center, Seattle, Washington, United States
Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant
Phase 2
Completed
- Conditions
- Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGAHypertension, Renal
- First Posted Date
- 2007-03-12
- Last Posted Date
- 2010-04-06
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 14
- Registration Number
- NCT00446251
SPHERE Hypertension Baseline Data Study
Completed
- Conditions
- Hypertension
- First Posted Date
- 2007-03-07
- Last Posted Date
- 2008-02-15
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 470
- Registration Number
- NCT00444496
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Computer Assisted Rx Education for HIV-Positives: CARE+
Not Applicable
Completed
- Conditions
- HIV InfectionsAcquired Immunodeficiency Syndrome
- Interventions
- Behavioral: CARE+
- First Posted Date
- 2007-03-06
- Last Posted Date
- 2008-01-29
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 240
- Registration Number
- NCT00443378
- Locations
- 🇺🇸
Madison Clinic, Harborview Medical Center, Seattle, Washington, United States
🇺🇸Lifelong AIDS Alliance, Seattle, Washington, United States
Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity
Phase 2
- Conditions
- Contraception
- Interventions
- First Posted Date
- 2007-02-26
- Last Posted Date
- 2011-02-14
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 36
- Registration Number
- NCT00439972
- Locations
- 🇺🇸
University of Washington, Northwest Lipid Research Clinic, Seattle, Washington, United States
SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)
Phase 2
Completed
- Conditions
- Mild Cognitive ImpairmentAlzheimer's Disease
- Interventions
- Drug: PlaceboDrug: Regular Insulin
- First Posted Date
- 2007-02-22
- Last Posted Date
- 2012-09-14
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 173
- Registration Number
- NCT00438568
- Locations
- 🇺🇸
Veterans Administration Puget Sound Health Care System, Seattle, Washington, United States
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer
Phase 1
Active, not recruiting
- Conditions
- Stage III Ovarian Epithelial CancerStage IV Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IV Ovarian Epithelial CancerStage IV Ovarian Germ Cell TumorHER2-positive Breast CancerStage IIIC Breast CancerStage III Ovarian Germ Cell Tumor
- Interventions
- Biological: pNGVL3-hICD vaccineBiological: sargramostimOther: flow cytometryOther: immunologic techniqueOther: immunoenzyme techniqueGenetic: protein expression analysisProcedure: biopsy
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 66
- Registration Number
- NCT00436254
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Effect of Diesel Exhaust Particulate Exposures on Endothelial Function in Humans
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2013-01-16
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 24
- Registration Number
- NCT00434005
- Locations
- 🇺🇸
Northlake Laboratory, Seattle, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath